Xiaobin Wang
Guangzhou, 510260, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC.
Journal: Journal of hepatology
Published: February 13, 2025
Acid-responsive engineered bacteria with aberrant In-Situ anti-PD-1 expression for post-ablation immunotherapy of hepatocellular carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 06, 2024
Anti-CTLA-4 antibody self-presented dendritic cell nanovesicles boost the immunotherapy of hepatocellular carcinoma after microwave ablation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 10, 2024
Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.
Journal: Biomaterials
Published: January 21, 2024
Microbial-derived Urolithin A Targets GLS1 to Inhibit Glutaminolysis and Attenuate Cirrhotic Portal Hypertension.
Journal: Cellular and molecular gastroenterology and hepatology
Published: December 22, 2023
HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation.
Journal: Hepatology communications
Published: February 23, 2023
T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 06, 2023
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation.
Journal: Bioactive materials
Published: June 24, 2022
Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 10, 2022
Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti-programmed cell death protein-1 therapy.
Journal: Hepatology (Baltimore, Md.)
Published: March 03, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026